Health care stocks fell Monday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.1%.
The iShares Biotechnology ETF (IBB) shed 0.3%.
In corporate news, BioNTech (BNTX) shares dropped 2.7% after the company reported an unexpected decline in Q1 sales.
Capricor Therapeutics (CAPR) shares tumbled past 10% after the company said the US Food and Drug Administration plans to hold an advisory committee meeting to review its biologics license application for deramiocel, an investigational cell therapy for treating cardiomyopathy in Duchenne muscular dystrophy patients.
Rezolute (RZLT) shares popped 2.9% after the company said the FDA granted breakthrough therapy designation for ersodetug, an investigational treatment for hypoglycemia caused by tumor hyperinsulinism.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。